Works matching IS 02770008 AND DT 2022 AND VI 42 AND IP 3
Results: 10
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 233, doi. 10.1002/phar.2667
- By:
- Publication type:
- Article
Successful prolonged treatment of a carbapenem‐resistant Acinetobacter baumannii hip infection with cefiderocol: A case report.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 268, doi. 10.1002/phar.2660
- By:
- Publication type:
- Article
Patient risk factors for opioid‐related adverse drug events in hospitalized patients: A systematic review.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 194, doi. 10.1002/phar.2666
- By:
- Publication type:
- Article
Response to intravenous racemic ketamine after switch from intranasal (S)‐ketamine on symptoms of treatment‐resistant depression and post‐traumatic stress disorder in Veterans: A retrospective case series.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 272, doi. 10.1002/phar.2664
- By:
- Publication type:
- Article
The role of inflammation in the pathogenesis and treatment of arrhythmias.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 250, doi. 10.1002/phar.2663
- By:
- Publication type:
- Article
Comparison of high‐dose dual therapy with bismuth‐containing quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: An open‐label, multicenter, randomized controlled trial.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 224, doi. 10.1002/phar.2662
- By:
- Publication type:
- Article
Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 263, doi. 10.1002/phar.2661
- By:
- Publication type:
- Article
Evaluation of anti‐factor Xa concentrations using a body mass index‐based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 216, doi. 10.1002/phar.2665
- By:
- Publication type:
- Article
Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid‐induced constipation: A nationwide retrospective cohort study in Japan.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 241, doi. 10.1002/phar.2658
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 3, p. 191, doi. 10.1002/phar.2417
- Publication type:
- Article